The Federal Circuit has agreed to an en banc hearing of a design patent case that may change the landscape of design patent invalidation in the U.S. The case is LKQ Corp. et al. v. G.M. Global Technology Operations LLC, case number 21-2348.
A recent court decision from the Northern District of California may significantly impact a common strategy, long accepted and practiced among patent holders.
The United States Patent and Trademark Office (USPTO) Director Vidal announced on July 24, 2023, that litigants can now request a review of Patent Trial and Appeal Board (PTAB) decisions to either institute or not institute patent challenges.
You may not know it, but November 8, 2023, marked a significant end date for the U.S. Patent and Trademark Office (USPTO).
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
Under U.S. law, patent marking is optional. One may ask, well, then why do it? The short answer; damages.
If your client’s invention is focused on, or relates to, achieving net-zero greenhouse gas emissions, the U.S. Patent and Trademark Office (USPTO) is in your corner, now more than ever. On June 6, 2023, the USPTO expanded the eligibility requirements of the Climate Change Mitigation Pilot Program to apply to a greater breadth of technologies.
In April 2023, the U.S. Patent & Trademark Office (USPTO) announced proposed changes to some of the fees that it charges with respect to patent applications, design patents and America Invents Act trials.
We would like to introduce you to Patent Lodge.
In the U.S., patents will soon be granted electronically starting April 18, 2023.
- Will Design Patents Become Easier to Challenge?
- Cause for Concern Regarding Continuation Practice?
- New PTAB Rule – Applicants Can Now Ask for the Director’s Review of PTAB Decisions
- Adieu to USPTO’s EFS-Web System and PAIR
- Amgen Inc. v. Sanofi: The Supreme Court Leaves Enablement Undisturbed
- Best Practices - Patent Marking - Why We Recommend It
- Good News for the Environment
- Proposed Fee Changes from the USPTO
- Welcome to Patent Lodge
- PTO Update: eGrants